Bluefin Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-84,800
Closed -$157K 281
2022
Q4
$157K Buy
84,800
+15,900
+23% +$1.19M 0.02% 237
2022
Q3
$311K Buy
+68,900
New +$5.4M 0.03% 229
2020
Q1
Sell
-45,200
Closed -$5K 459
2019
Q4
$5K Sell
45,200
-306,300
-87% -$20.9M ﹤0.01% 551
2019
Q3
$54K Buy
+351,500
New +$25.5M 0.01% 361
2019
Q2
Sell
-20,200
Closed -$64K 349
2019
Q1
$64K Buy
+20,200
New +$1.3M 0.01% 275
2017
Q3
Sell
-100,000
Closed -$63K 498
2017
Q2
$63K Sell
100,000
-170,300
-63% -$12.6M 0.01% 401
2017
Q1
$168K Buy
+270,300
New +$18.9M 0.02% 298

Other funds holding CL

Bluefin Capital Management's CL Position: Q1 2023 in Review

Bluefin Capital Management sold out of Colgate-Palmolive (CL) in Q1 2023, closing a stake of 36,133 shares — an estimated $2.85M sold.

Bluefin Capital Management first reported a position in CL in Q4 2013 and held it in 10 quarters. The position peaked at $60.9M in Q2 2019. 1,658 funds tracked by Wall St. Rank hold CL as of Q1 2023.

  • Bluefin Capital Management reported no remaining Colgate-Palmolive position as of Q1 2023 after selling out during the quarter.
  • Bluefin Capital Management sold 36,133 Colgate-Palmolive shares in Q1 2023, an estimated $2.85M.
  • Bluefin Capital Management first reported a position in Colgate-Palmolive in Q4 2013 and held it in 10 quarters.
  • Bluefin Capital Management's Colgate-Palmolive position peaked at $60.9M in Q2 2019.
  • 1,658 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2023.

Based on Bluefin Capital Management's 13F filing for Q1 2023, filed 15 May 2023.